Algunos números, algunas reflexiones: carta del presidente de la SAC
Masoli, Osvaldo H.
Rev. argent. cardiol
; 75(3): 231-231, mayo-jun. 2007.
Artículo en Español | LILACS | ID: lil-613255
Documentos relacionados
Invited commentary.
Drug-Eluting Resorbable Scaffold for Infrapopliteal Artery Disease. Reply.
Drug-Eluting Resorbable Scaffold for Infrapopliteal Artery Disease.
Drug-Eluting Resorbable Scaffold for Infrapopliteal Artery Disease.
The effectiveness of a motivational text-messaging program for smoking cessation after coronary angioplasty: a quasi-experimental study.
Selective referral or learning by doing? An analysis of hospital volume-outcome relationship of vascular procedures.
Letter by Su et al Regarding Article, "Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease)".
Response by Weinberg et al to Letter Regarding Article, "Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease)".
Tandem Occlusions: A Tale of Two Treatments.
Paclitaxel and Mortality: Where Are We now?